--- title: "Ab&B Bio-Tech to Scrap Supervisory Committee and Revamp Governance Framework" type: "News" locale: "en" url: "https://longbridge.com/en/news/283252438.md" description: "Ab&B Bio-Tech CO., LTD. JS plans to abolish its Supervisory Committee and transfer oversight functions to the Board’s Audit Committee, aligning governance with operational needs and PRC company law. This change, subject to shareholder approval, will streamline internal oversight and amend the Articles of Association. Additionally, the company has reconstituted its Strategy Committee, appointing An Youcai as chairman, indicating a refreshed governance framework. Ab&B Bio-Tech operates in the biotechnology sector and is listed in Hong Kong, focusing on bio-tech products and services in the life sciences and healthcare supply chain." datetime: "2026-04-19T11:37:16.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283252438.md) - [en](https://longbridge.com/en/news/283252438.md) - [zh-HK](https://longbridge.com/zh-HK/news/283252438.md) --- # Ab&B Bio-Tech to Scrap Supervisory Committee and Revamp Governance Framework ### Claim 30% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks The latest update is out from Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ). Ab&B Bio-Tech CO., LTD. JS plans to abolish its Supervisory Committee and transfer its statutory oversight functions to the Board’s Audit Committee, a move that aligns the company’s governance structure with its operational needs and the latest requirements of PRC company law. The change would also terminate existing supervisor positions and streamline internal oversight processes, subject to shareholder approval at a forthcoming general meeting. The company will amend its Articles of Association to reflect the removal of the Supervisory Committee, update provisions in line with new regulatory standards, and perform textual and structural clean-up. In parallel, Ab&B Bio-Tech has reconstituted its Strategy Committee, appointing chairman An Youcai alongside members He Yiming and Li Xiangming, signaling a refreshed strategic governance framework at board level. **More about Ab&B Bio-Tech CO., LTD. JS Class H** Ab&B Bio-Tech CO., LTD. JS is a mainland China-based joint stock company listed in Hong Kong, operating in the biotechnology sector. Through its group structure, it focuses on bio-tech products and related services, positioning itself within the broader life sciences and healthcare supply chain in the Chinese and regional markets. **Average Trading Volume:** 740,312 **Technical Sentiment Signal:** Strong Sell **Current Market Cap:** HK$11.54B Find detailed analytics on 2627 stock on TipRanks’ Stock Analysis page. ### Related Stocks - [02627.HK](https://longbridge.com/en/quote/02627.HK.md) - [588130.CN](https://longbridge.com/en/quote/588130.CN.md) - [516500.CN](https://longbridge.com/en/quote/516500.CN.md) - [588250.CN](https://longbridge.com/en/quote/588250.CN.md) - [159859.CN](https://longbridge.com/en/quote/159859.CN.md) - [159615.CN](https://longbridge.com/en/quote/159615.CN.md) - [516820.CN](https://longbridge.com/en/quote/516820.CN.md) - [510660.CN](https://longbridge.com/en/quote/510660.CN.md) - [159992.CN](https://longbridge.com/en/quote/159992.CN.md) - [513120.CN](https://longbridge.com/en/quote/513120.CN.md) - [159316.CN](https://longbridge.com/en/quote/159316.CN.md) - [159892.CN](https://longbridge.com/en/quote/159892.CN.md) - [520880.CN](https://longbridge.com/en/quote/520880.CN.md) - [159506.CN](https://longbridge.com/en/quote/159506.CN.md) - [520690.CN](https://longbridge.com/en/quote/520690.CN.md) - [159837.CN](https://longbridge.com/en/quote/159837.CN.md) - [513700.CN](https://longbridge.com/en/quote/513700.CN.md) - [516930.CN](https://longbridge.com/en/quote/516930.CN.md) - [159102.CN](https://longbridge.com/en/quote/159102.CN.md) - [512290.CN](https://longbridge.com/en/quote/512290.CN.md) - [159849.CN](https://longbridge.com/en/quote/159849.CN.md) ## Related News & Research - [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md) - [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md) - [Fingerprint Cards AB Bets on Merger-Led Turnaround](https://longbridge.com/en/news/286333864.md) - [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md) - [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)